Biotech ETF Overview

With 15 ETFs traded in the U.S. markets, Biotech ETFs gather total assets under management of $20.09B. The average expense ratio is 0.72%. Biotech ETFs can be found in the following asset classes:

  • Equity

The largest Biotech ETF is the iShares NASDAQ Biotechnology ETF IBB with $10.00B in assets. In the last trailing year, the best performing Biotech ETF was the BBC at 50.64%. The most-recent ETF launched in the Biotech space was the ETFMG Treatments Testing and Advancements ETF GERM in 06/17/20.


ETF Prime Podcast: 2020 Halftime Report

Recapping ETFs at the halfway point of the year.

Features and News

Hot & Cold Health Care ETF Returns

Health care ETFs have diverged sharply as some stocks benefit from the pursuit of virus treatments, others not so much. Analysis

Biotech ETFs: Appraising The Pipelines

Parsing the performance and holdings of different biotech funds. Analysis

Thematic ETFs The New Sectors?

Sometimes an idea just gets you thinking about the possibilities.

ETF Report

Sectors In Review: May 2020

None of the sector ETFs managed to eke out a positive return during the month.

ETF Report

Sectors In Review: April 2020

February was awful for sectors, with just one fund recording positive returns.

ETF Strategist Corner

Alpha's Not Dead

Like punk rock, alpha is very much alive. 


ETF Prime Podcast: Companies Targeting The Virus

Biotech expert Brad Loncar goes in-depth on coronavirus treatments and vaccines.

Features and News

Leveraged ETF Closures Piling Up

Since the market volatility began, almost 30 leveraged and inverse products have shut up shop. But why now?